Alcon AG | ALC - Capital De Empréstimo





Capital De Empréstimo Alterar Data
AstraZeneca USD 25.96B 177M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Essilor EUR 9.46B 92M 2025-12
Fresenius EUR 9.22B 1.58B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Philips EUR 6.89B 43M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Smith & Nephew USD 3.3B 22M 2025-12
Sonova Holding CHF 1.39B 209.8M 2025-06
UCB EUR 2.18B 634M 2025-12